Blood-Derived Plasma Protein Biomarkers for Alzheimer's Disease in Han Chinese
- PMID: 30618720
- PMCID: PMC6305130
- DOI: 10.3389/fnagi.2018.00414
Blood-Derived Plasma Protein Biomarkers for Alzheimer's Disease in Han Chinese
Abstract
It is well known that Alzheimer's disease (AD) is one of the most common progressive neurodegenerative diseases; it begins gradually, and therefore no effective medicine is administered in the beginning. Thus, early diagnosis and prevention of AD are crucial. The present study focused on comparing the plasma protein changes between patients with AD and their healthy counterparts, aiming to explore a specific protein panel as a potential biomarker for AD patients in Han Chinese. Hence, we recruited and collected plasma samples from 98 AD patients and 101 elderly healthy controls from Wuxi and Shanghai Mental Health Centers. Using a Luminex assay, we investigated the expression levels of fifty plasma proteins in these samples. Thirty-two out of 50 proteins were found to be significantly different between AD patients and healthy controls (P < 0.05). Furthermore, an eight-protein panel that included brain-derived neurotrophic factor (BDNF), angiotensinogen (AGT), insulin-like growth factor binding protein 2 (IGFBP-2), osteopontin (OPN), cathepsin D, serum amyloid P component (SAP), complement C4, and prealbumin (transthyretin, TTR) showed the highest determinative score for AD and healthy controls (all P = 0.00). In conclusion, these findings suggest that a combination of eight plasma proteins can serve as a promising diagnostic biomarker for AD with high sensitivity and specificity in Han Chinese populations; the eight plasma proteins were proven important for AD diagnosis by further cross-validation studies within the AD cohort.
Keywords: Alzheimer’s disease; Han Chinese; biomarker; early diagnosis; plasma protein.
Figures
Similar articles
-
Human serum transthyretin levels correlate inversely with Alzheimer's disease.J Alzheimers Dis. 2011;25(1):77-84. doi: 10.3233/JAD-2011-102145. J Alzheimers Dis. 2011. PMID: 21335655
-
Long Non-coding RNA BACE1-AS May Serve as an Alzheimer's Disease Blood-Based Biomarker.J Mol Neurosci. 2019 Nov;69(3):351-359. doi: 10.1007/s12031-019-01364-2. Epub 2019 Jul 1. J Mol Neurosci. 2019. PMID: 31264051 Clinical Trial.
-
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease.Psychoneuroendocrinology. 2013 Sep;38(9):1729-37. doi: 10.1016/j.psyneuen.2013.02.006. Epub 2013 Mar 6. Psychoneuroendocrinology. 2013. PMID: 23473966
-
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8. Eur J Med Chem. 2019. PMID: 30877973 Review.
-
Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings.Prog Mol Biol Transl Sci. 2019;168:3-23. doi: 10.1016/bs.pmbts.2019.07.006. Epub 2019 Jul 24. Prog Mol Biol Transl Sci. 2019. PMID: 31699324 Review.
Cited by
-
Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review.Front Aging Neurosci. 2022 Mar 11;14:683689. doi: 10.3389/fnagi.2022.683689. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35360215 Free PMC article.
-
Blood-based protein mediators of senility with replications across biofluids and cohorts.Brain Commun. 2019 Nov 22;2(1):fcz036. doi: 10.1093/braincomms/fcz036. eCollection 2020. Brain Commun. 2019. PMID: 32954311 Free PMC article.
-
Cerebrospinal fluid YKL-40 level evolution is associated with autoimmune encephalitis remission.Clin Transl Immunology. 2023 Mar 15;12(3):e1439. doi: 10.1002/cti2.1439. eCollection 2023. Clin Transl Immunology. 2023. PMID: 36938371 Free PMC article.
-
Early Diagnosis of Alzheimer's Disease with Blood Test; Tempting but Challenging.Int J Mol Cell Med. 2023;12(2):172-210. doi: 10.22088/IJMCM.BUMS.12.2.172. Int J Mol Cell Med. 2023. PMID: 38313372 Free PMC article. Review.
-
The Effect of Nutrients on Alzheimer's Disease Biomarkers: A Metabolomic Approach.Adv Exp Med Biol. 2021;1339:301-308. doi: 10.1007/978-3-030-78787-5_35. Adv Exp Med Biol. 2021. PMID: 35023117
References
-
- Al-Daghri N. M., Yakout S. M., Wani K., Khattak M. N. K., Garbis S. D., Chrousos G. P., et al. (2018). IGF and IGFBP as an index for discrimination between vitamin D supplementation responders and nonresponders in overweight Saudi subjects. Medicine 97:e0702. 10.1097/MD.0000000000010702 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous